Centronuclear myopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Utility of next generation sequencing in genetic diagnosis of early onset neuromuscular disorders.
|
25635128 |
2015 |
Centronuclear myopathy
|
0.500 |
Biomarker
|
disease |
CLINGEN |
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores.
|
22818856 |
2012 |
MYOPATHY, CENTRONUCLEAR, 4
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores.
|
22818856 |
2012 |
MYOPATHY, CENTRONUCLEAR, 4
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores.
|
22818856 |
2012 |
MYOPATHY, CENTRONUCLEAR, 4
|
0.500 |
GermlineCausalMutation
|
disease |
ORPHANET |
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores.
|
22818856 |
2012 |
MYOPATHY, CENTRONUCLEAR, 4
|
0.500 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores.
|
22818856 |
2012 |
Centronuclear myopathy
|
0.500 |
Biomarker
|
disease |
CTD_human |
|
|
|
X-linked centronuclear myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Tubular Aggregate Myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Congenital Fiber Type Disproportion
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Congenital Structural Myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Myopathy, Centronuclear, Autosomal Dominant
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autosomal Recessive Centronuclear Myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Autosomal Dominant Myotubular Myopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Myopathy, Centronuclear, 1
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Fatigue
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Muscle Weakness
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myalgia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Impaired cognition
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Centrally nucleated skeletal muscle fibers
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Myopathy
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Using a combination of linkage analysis, next-generation sequencing, and modeling in the zebrafish, we have identified a CCDC78 mutation associated with a unique myopathy with prominent internal nuclei and atypical cores.
|
22818856 |
2012 |
Congenital myopathy (disorder)
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Dominant mutation of CCDC78 in a unique congenital myopathy with prominent internal nuclei and atypical cores.
|
22818856 |
2012 |